A phase 2 single-arm trial of high-dose precision targeted radiotherapy added to immunotherapy for patients with metastatic non-small cell lung cancer.
Gensheimer MF, Kotha NV, Vitzthum LK, Chin AL, Jackson S, 't Erve IV, Pratapneni A, Le-Budka ML, Wong S, Brown E, Barnick K, Wakelee HA, Das M, Ramchandran KJ, Myall NJ, Padda S, Marquez CM, Million L, Chen TT, Man MC, Cabebe EC, Chen MC, Hiniker S, Hancock SL, Swift PS, Diehn M, Loo BW, Neal JW.
Gensheimer MF, et al. Among authors: million l.
Int J Radiat Oncol Biol Phys. 2024 Sep 25:S0360-3016(24)03410-2. doi: 10.1016/j.ijrobp.2024.09.038. Online ahead of print.
Int J Radiat Oncol Biol Phys. 2024.
PMID: 39357790